脑深部电刺激脉冲发生器植入后装置感染与侵蚀再手术分析
该研究回顾性分析2013至2016年单中心995例次脑深部电刺激脉冲发生器手术,发现感染再手术率2.7%、侵蚀再手术率1.6%,两者时间线和危险因素不同,提示病因不同。
要点
- 感染再手术中位时间51天,侵蚀为149天,提示两者病因不同。
- 既往感染显著增加再感染风险(OR 35.0)。
- 低BMI(≤24 kg/m2)是侵蚀的危险因素(OR 3.1)。
核心结论
- 脉冲发生器相关感染和侵蚀不常见但具有临床意义,其时间线和危险因素提示不同病因及不同矫正措施。
研究设计与样本
- 回顾性队列研究,纳入2013至2016年单中心因运动障碍接受DBS手术的连续脉冲发生器植入和更换病例,共384例患者995次手术,中位随访2.9年。
主要发现
- 感染再手术发生于27次手术(2.7%)共21例患者(5.5%),初次植入与更换的感染率无差异(p=0.838)。
- 侵蚀再手术发生于16次手术(1.6%)共15例患者(3.9%)。
- 感染再手术中位时间51天(IQR 24-129天),侵蚀再手术中位时间149天(IQR 112-285天)。
- 4例感染患者(19.0%)发生第二次感染需同侧再手术,其中2例发生第三次感染。
- 术中万古霉素粉末使用158例(15.9%),未降低感染风险(使用组感染率3.2% vs 未使用组2.6%,p=0.922,log-rank检验)。
关键数值与推荐
- 既往感染增加感染风险(OR 35.0,95%CI 7.9-156.2,p<0.0001)。
- 较低BMI是侵蚀的危险因素(BMI≤24 kg/m2:OR 3.1,95%CI 1.1-8.6,p=0.03)。
临床怎么用
- 对既往有感染史的患者应加强监测和预防措施。
- 低BMI患者需警惕侵蚀风险,关注切口愈合和装置覆盖。
- 术中万古霉素粉末未显示降低感染风险,需谨慎评估其使用。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Infection and erosion following implantable pulse generator (IPG) placement are associated with morbidity and cost for patients with deep brain stimulation (DBS) systems. Here, the authors provide a detailed characterization of infection and erosion events in a large cohort that underwent DBS surgery for movement disorders. METHODS: The authors retrospectively reviewed consecutive IPG placements and replacements in patients who had undergone DBS surgery for movement disorders at the University of Alabama at Birmingham between 2013 and 2016. IPG procedures occurring before 2013 in these patients were also captured. Descriptive statistics, survival analyses, and logistic regression were performed using generalized linear mixed effects models to examine risk factors for the primary outcomes of interest: infection within 1 year or erosion within 2 years of IPG placement. RESULTS: In the study period, 384 patients underwent a total of 995 IPG procedures (46.4% were initial placements) and had a median follow-up of 2.9 years. Reoperation for infection occurred after 27 procedures (2.7%) in 21 patients (5.5%). No difference in the infection rate was observed for initial placement versus replacement (p = 0.838). Reoperation for erosion occurred after 16 procedures (1.6%) in 15 patients (3.9%). Median time to reoperation for infection and erosion was 51 days (IQR 24-129 days) and 149 days (IQR 112-285 days), respectively. Four patients with infection (19.0%) developed a second infection requiring a same-side reoperation, two of whom developed a third infection. Intraoperative vancomycin powder was used in 158 cases (15.9%) and did not decrease the infection risk (infected: 3.2% with vancomycin vs 2.6% without, p = 0.922, log-rank test). On logistic regression, a previous infection increased the risk for infection (OR 35.0, 95% CI 7.9-156.2, p < 0.0001) and a lower patient BMI was a risk factor for erosion (BMI ≤ 24 kg/m2: OR 3.1, 95% CI 1.1-8.6, p = 0.03). CONCLUSIONS: IPG-related infection and erosion following DBS surgery are uncommon but clinically significant events. Their respective timelines and risk factors suggest different etiologies and thus different potential corrective procedures.
引用
- Atchley TJ, Laskay NMB, Sherrod BA, et al. Reoperation for device infection and erosion following deep brain stimulation implantable pulse generator placement. J Neurosurg. 2019. PMID: 31174189. doi:10.3171/2019.3.JNS183023
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。